@article{31a47c80bab9414cb968b9725ec76df5,
title = "High PDGFRA expression does not serve as an effective therapeutic target in ERG-deleted B-cell precursor acute lymphoblastic leukemia",
keywords = "Cell Survival, Child, Humans, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Receptor, Platelet-Derived Growth Factor alpha/metabolism, Transcriptional Regulator ERG/deficiency, Treatment Failure",
author = "Jerchel, \{Isabel S\} and Danai Chatzivasileiou and Hoogkamer, \{Alex Q\} and Boer, \{Judith M\} and Beverloo, \{H Berna\} and Rob Pieters and \{den Boer\}, \{Monique L\}",
note = "Funding Information: 1Department of Pediatric Oncology, Erasmus Medical Center-Sophia Children{\textquoteright}s Hospital, Rotterdam;2Department of Clinical Genetics, Erasmus Medical Center, Rotterdam and 3Princess M{\'a}xima Center for Pediatric Oncology, Utrecht, the Netherlands Funding: this work was supported by NWO (grant 016.126.612), the Dutch Cancer Society (AMC 2008-4265 and EMCR 2014-6998), the KIKA Foundation (132 and 161) and the Pediatric Oncology Foundation Rotterdam. We thank Cergentis BV (Utrecht) for targeted locus amplification, and Judit Balog from Leiden University Medical Center for all efforts in detecting DUX4. Correspondence:
[email protected] doi:10.3324/haematol.2017.171702 Information on authorship, contributions, and financial \& other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.",
year = "2018",
month = feb,
doi = "10.3324/haematol.2017.171702",
language = "English",
volume = "103",
pages = "e73--e77",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "2",
}